M. ESSEX, D.V.M., Ph.D.; J. ALLAN, D.V.M.; P. KANKI, D.V.M.; M. F. McLANE, B.A.; G. MALONE, D.V.M., M.P.H.; L. KITCHEN, M.D.; T. H. LEE, D.Sc.
Antigens encoded by the gag and env genes of the human T-lymphotropic virus type lll/lymphadenopathy associated virus (HTLV-III/LAV) include a p55 gag polyprotein that yields p24 as the major virus core protein, and an env gene polyprotein, gp160, that produces gp120, the most immunogenic protein in humans, at the amino terminus. Although its use is limited to research laboratories due to the cost and specialized procedures involved, the analysis of sera by radioimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis is the test providing the optimal balance of specificity and sensitivity. Because the gp120 represents the external virus protein, it would be the most appropriate antigen for vaccine development. Also viruses serologically related to HTLV-III/LAV were detected recently in two species of Old World monkeys. Because about half the healthy African green monkeys appear to have been exposed to Simian T-lymphotropic virus type III (STLV-III), a related agent of the species, a characterization of the STLV-III gp120 and immune response of the host may provide additional information for vaccine development.
ESSEX M, ALLAN J, KANKI P, McLANE MF, MALONE G, KITCHEN L, et al. Antigens of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus. Ann Intern Med. ;103:700–703. doi: 10.7326/0003-4819-103-5-700
Download citation file:
Published: Ann Intern Med. 1985;103(5):700-703.
HIV, Infectious Disease, Prevention/Screening.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use